HIGHLIGHTS
- who: Per Ljungman from the Radboud University Medical Center, Nijmegen, the Netherlands have published the article: The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy, in the Journal: (JOURNAL)
- future: In the light of substantial and ongoing disruption caused by the international COVID-19 pandemic which has made normal JACIE accreditation services difficult or impossible to maintain in the foreseeable future the EBMT took the decision to extend current accreditations by 12 months and to give coverage . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.